StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Here is a head-scratcher for IR to answer.

<< Previous

Bullboard Posts

Next >>

Comment by MarketMoneyon Dec 29, 2020 11:39pm

188 Views

Post# 32195034

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Here is a head-scratcher for IR to answer.

Nailbiter1 wrote: I just listened to the investor conference replay.
This is a complete ripoff of SZLS. They mentioned they use ColonSentry and have ventured
into the other phases that we are testing (apart from cancer).
Cardiac, neurology, musculoskeletal etc...
They mentioned they are testing in the US and Canada.
This will be brought up to Tripp.

MarketMoney wrote:

Newfinvest wrote: What the hell is this all about??? Thanks for the info guys but what the heck is this? Waiting patiently for news on Aristotle in Q1 and this all of a sudden come sto light. I hope SZLS stands up and makes a statement or adds clarity on it. Do we need to lawyer up?

At first look, BGLC is listed on the OTCmarket more precisely on the OTCQB.....by the look at the bid and ask spread and volume....let say it's kind of VERY speculative company and there's a reason why they are trading on the OTCQB so if they really are in infrigememt that would cost them alot of money and could easily end the company, you have to be a big company to defend this unless you settle for an amount instead of going on court.

So maybe they are using something based on the sentinel principle but different enough to not be considered as infrigement...

Nothing to be worry about unless you are in the wrong side and we are in the right side with patents to support SZLS :-)